Loading clinical trials...
Loading clinical trials...
A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Respiratory Viral Infection in Children Aged 3-12 Years
Conditions
Interventions
Raphamin
Placebo
Locations
35
Russia
Gatchina Clinical Interdistrict Hospital
Gatchina, Russia
Kazan State Medical University/Department of Hospital Pediatrics
Kazan', Russia
LLC "MedLight"
Kazan', Russia
Regional Clinical Hospital # 2
Krasnodar, Russia
Specialized Clinical Infectious Diseases Hospital
Krasnodar, Russia
Central Research Institute of Epidemiology/Clinical Department of Infectious Pathology
Moscow, Russia
Start Date
November 11, 2024
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2027
Last Updated
March 13, 2026
NCT04682444
NCT02072174
Lead Sponsor
Materia Medica Holding
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions